MedPath

人福普克药业(武汉)有限公司

Ownership
-
Established
2009-09-03
Employees
-
Market Cap
-
Website
www.puracap.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Omega-3-acid ethyl ester 90 Soft Capsules

Product Name
ω-3脂肪酸乙酯90软胶囊
Approval Number
国药准字H20244572
Approval Date
Oct 15, 2024
NMPA

Eldecalcitol Soft Capsules

Product Name
艾地骨化醇软胶囊
Approval Number
国药准字H20243290
Approval Date
Feb 23, 2024
NMPA

Eldecalcitol Soft Capsules

Product Name
艾地骨化醇软胶囊
Approval Number
国药准字H20243289
Approval Date
Feb 23, 2024
NMPA

Dutasteride Soft Capsules

Product Name
度他雄胺软胶囊
Approval Number
国药准字H20234127
Approval Date
Jan 19, 2024
NMPA

Nintedanib Esilate Soft Capsules

Product Name
乙磺酸尼达尼布软胶囊
Approval Number
国药准字H20234165
Approval Date
Sep 12, 2023
NMPA

Nintedanib Esilate Soft Capsules

Product Name
乙磺酸尼达尼布软胶囊
Approval Number
国药准字H20234164
Approval Date
Sep 12, 2023
NMPA

Ibuprofen Soft Capsules

Product Name
布洛芬软胶囊
Approval Number
国药准字H20223377
Approval Date
Jun 7, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.